Cannabis Derivatives Show Promise in Ovarian Cancer Treatment Recent laboratory research has shed light on the potential of cannabis compounds to combat ovarian cancer.
Cannabis Derivatives Show Promise in Ovarian Cancer Treatment
Recent laboratory research has shed light on the potential of cannabis compounds to combat ovarian cancer. The study found that two primary cannabinoids, THC and CBD, demonstrated potent anti-tumor effects when exposed to ovarian cancer cells.
The findings suggest that these compounds may work synergistically to reduce cancer cell growth, spread, and survival in multiple ways. This breakthrough could pave the way for new adjunct therapies that support both treatment effectiveness and patient quality of life.
THC and CBD are two of the most widely studied compounds found in cannabis, with THC being the primary psychoactive compound and CBD being a non-intoxicating compound. Both belong to a class of compounds known as cannabinoids, which work on the body's endocannabinoid system.
Cannabis has been used therapeutically for various conditions, including nausea and chronic pain. The study highlights the potential of these compounds in cancer treatment, particularly in gynecologic cancers such as ovarian cancer.
Researchers conducted a series of in vitro studies exposing ovarian cancer cells to CBD and THC in laboratory experiments. The results showed that both compounds killed ovarian cancer cells and slowed markers of tumor growth.
"Our findings are consistent with existing literature showing that CBD and THC can act as potential adjuncts to cancer therapy," said Siyao Tong, MD, an attending obstetrician and gynecologist at First Affiliated Hospital of Jinzhou Medical University, China. "Both CBD and THC demonstrated clear inhibitory effects on ovarian cancer cells, and their combination showed the strongest anticancer activity."
Experts hail this research as a significant step forward in the search for new cancer treatments. "This is a field that is very much looking for new approaches," said Elena Ratner, MD, a professor of obstetrics, gynecology, and reproductive sciences at Yale School of Medicine.
Cannabis Compounds Target Ovarian Cancer Cells
Tong's team conducted in vitro studies exposing ovarian cancer cells to CBD and THC. They experimented with two different ovarian cancer cell lines — one platinum-resistant and one platinum-sensitive. The results showed that both compounds killed ovarian cancer cells and slowed markers of tumor growth.
Learn more about hair transplant at Rubenhair clinic.
Get a Free Consultation
Consult with our specialists about FUE procedure, PRP therapy or hair transplant.
